Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Dec;68(6):1232–1235. doi: 10.1038/bjc.1993.510

Are plant factors a missing link in the evolution of endemic Burkitt's lymphoma?

C van den Bosch 1, B E Griffin 1, P Kazembe 1, C Dziweni 1, L Kadzamira 1
PMCID: PMC1968631  PMID: 8260378

Abstract

Burkitt's lymphoma, an Epstein-Barr virus (EBV)-associated non-Hodgkin's malignant lymphoma is endemic in an area of Africa known as the Lymphoma Belt. This zone is demarcated by climatic requirements of temperature and rainfall. EBV-activating plant factors are among several co-factors which have been proposed for the development of epidemic Burkitt's Lymphoma (eBL). The distribution of Euphorbia tirucalli, a plant which possesses EBV-activating substances and can induce the characteristic 8:14 translocation of eBL in EBV-infected lymphoblastic cell lines in vitro, conforms closely to the climatic requirements of the Lymphoma. This plant, other EBV-activating plants and plants of unknown EBV-activating status with medicinal uses, are found significantly more often at the homes of eBL patients in Malawi than in those of controls. The possible role of these plant factors in the pathogenesis of eBL and their routes of bodily access are discussed. It is postulated that the associations described in this paper provide support for the theory that EBV-activating plants are co-factors involved in the pathogenesis of some cases of eBL.

Full text

PDF
1232

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aya T., Kinoshita T., Imai S., Koizumi S., Mizuno F., Osato T., Satoh C., Oikawa T., Kuzumaki N., Ohigashi H. Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes. Lancet. 1991 May 18;337(8751):1190–1190. doi: 10.1016/0140-6736(91)92861-u. [DOI] [PubMed] [Google Scholar]
  2. Fürstenberger G., Schurich B., Kaina B., Petrusevska R. T., Fusenig N. E., Marks F. Tumor induction in initiated mouse skin by phorbol esters and methyl methanesulfonate: correlation between chromosomal damage and conversion ('stage I of tumor promotion') in vivo. Carcinogenesis. 1989 Apr;10(4):749–752. doi: 10.1093/carcin/10.4.749. [DOI] [PubMed] [Google Scholar]
  3. Geser A., Lenoir G. M., Anvret M., Bornkamm G., Klein G., Williams E. H., Wright D. H., De-The G. Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda. Eur J Cancer Clin Oncol. 1983 Oct;19(10):1393–1404. doi: 10.1016/0277-5379(93)90009-t. [DOI] [PubMed] [Google Scholar]
  4. HADDOW A. J. AN IMPROVED MAP FOR THE STUDY OF BURKITT'S LYMPHOMA SYNDROME IN AFRICA. East Afr Med J. 1963 Sep;40:429–432. [PubMed] [Google Scholar]
  5. Ito Y., Ohigashi H., Koshimizu K., Yi Z. Epstein-Barr virus-activating principle in the ether extracts of soils collected from under plants which contain active diterpene esters. Cancer Lett. 1983 Jun;19(2):113–117. doi: 10.1016/0304-3835(83)90144-1. [DOI] [PubMed] [Google Scholar]
  6. Kafuko G. W., Burkitt D. P. Burkitt's lymphoma and malaria. Int J Cancer. 1970 Jul 15;6(1):1–9. doi: 10.1002/ijc.2910060102. [DOI] [PubMed] [Google Scholar]
  7. Williams E. H., Smith P. G., Day N. E., Geser A., Ellice J., Tukei P. Space-time clustering of Burkitt's lymphoma in the West Nile district of Uganda: 1961-1975. Br J Cancer. 1978 Jan;37(1):109–122. doi: 10.1038/bjc.1978.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. de-Thé G., Geser A., Day N. E., Tukei P. M., Williams E. H., Beri D. P., Smith P. G., Dean A. G., Bronkamm G. W., Feorino P. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature. 1978 Aug 24;274(5673):756–761. doi: 10.1038/274756a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES